Increased simplicity, broader financial risk sharing, and an enhanced focus on patient care were among the recommendations developed by diverse stakeholders at a recent AMCP Partnership Forum focused on how to better manage the high costs of specialty medications.
In December 2016, AMCP applauded the passage of the 21st Century Cures Act as it included many provisions that will directly improve the health of Americans, from prompting new cures for cancer to combating opioid addiction.
Digital therapeutics: What are they, and where do they fit into pharmacy and medical benefits? Learn more in this blog post from AMCP CEO Susan A. Cantrell, RPh, CAE.
AMCP CEO Blog: With PA so often misunderstood, perhaps we need to do a better job of explaining this tool to the general public. For example, we might provide an example of how PAs are applied to opioids as additional safeguards to ensure their appropriate use. Or how a PA might be applied to botulinum toxin to ensure the prescription is for medical, rather than cosmetic, purposes.
By AMCP CEO Susan A. Cantrell, RPh, CAE • 11/13/19
November 2019 News & Views: Read articles on AMCP Nexus 2019 draws record attendance; AMCP launches Champion Month in November; AMCP welcomes its latest Affiliate: AMCP Great Plains
AMCP Joins Stakeholder Letter to SAMHSA on Proposed Rule to Update 42 CFR Part 2; AMCP Seeks Input on Proposed Rule to Change Anti-Kickback Statute; CMS Issues Price Transparency Rules
for Hospital and Insurers
National Harbor, Md., Oct. 29, 2019 — AMCP Nexus 2019 will welcome nearly 2,500 managed care pharmacy professionals from across the country this week for four days of educational and networking programs focused on the “intersection of value and care.”